10.4103/aja202533

Editorial comment on “Outcomes and management of Peyronie’s disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil”

Gelbard, Martin K

UCLA Urology, Los Angeles, CA 90095, USA

Correspondence: Dr. MK Gelbard (mgelbard@g.ucla.edu)

Originally published: May 13, 2025 Received: March 5, 2025 Accepted: March 26, 2025